Update Note: This article reports new information on Medicare's GLOBE drug pricing model following MedicalDaily's earlier coverage. The latest verified development is a complaint filed Nov. 6, 2026, in the U.S. District Court for the Northern District of California.
Three biotechnology trade groups sued on Nov. 6 to block Medicare's GLOBE model, which would tie rebates on certain Part B drugs to prices in 19 other countries. It is the second legal challenge to the model and the first filed in California, home to two of the nation's largest biotech hubs.